Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |